Consolidated Portfolio Review Corp’s AllianzIM U.S. Equity Buffer20 Feb ETF FEBW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,573
Closed -$350K 159
2025
Q3
$350K Hold
10,573
0.04% 336
2025
Q2
$338K Buy
10,573
+2,280
+27% +$70K 0.05% 327
2025
Q1
$252K Buy
+8,293
New +$257K 0.04% 323
2024
Q4
Sell
-8,928
Closed -$271K 379
2024
Q3
$271K Buy
+8,928
New +$267K 0.06% 262

Other funds holding FEBW

Consolidated Portfolio Review Corp's FEBW Position: Q4 2025 in Review

Consolidated Portfolio Review Corp sold out of AllianzIM U.S. Equity Buffer20 Feb ETF (FEBW) in Q4 2025, closing a stake of 10,573 shares — an estimated $350K sold.

Consolidated Portfolio Review Corp first reported a position in FEBW in Q3 2024 and held it in 4 quarters. The position peaked at $350K in Q3 2025. 47 funds tracked by Wall St. Rank hold FEBW as of Q4 2025.

  • Consolidated Portfolio Review Corp reported no remaining AllianzIM U.S. Equity Buffer20 Feb ETF position as of Q4 2025 after selling out during the quarter.
  • Consolidated Portfolio Review Corp sold 10,573 AllianzIM U.S. Equity Buffer20 Feb ETF shares in Q4 2025, an estimated $350K.
  • Consolidated Portfolio Review Corp first reported a position in AllianzIM U.S. Equity Buffer20 Feb ETF in Q3 2024 and held it in 4 quarters.
  • Consolidated Portfolio Review Corp's AllianzIM U.S. Equity Buffer20 Feb ETF position peaked at $350K in Q3 2025.
  • 47 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer20 Feb ETF as of Q4 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2025, filed 26 Jan 2026.